Healthcare, Life Sciences and Pharmaceuticals · Published Aug 2026
Long-term Care Software Market
The global long-term care software market is projected to grow from USD 2,775.0 million in 2025 to USD 7,879.39 million by 2035, expanding at a compound annual growth rate (CAGR) of 11.0%. This growth is driven by increasing demand for efficient patient management, a rising aging population, and the need for digital healthcare solutions to improve care quality and operational efficiency. Key segments include EHR, eMAR, and payroll management systems, with cloud-based deployment leading the market.
North America currently leads the market, while Asia-Pacific is expected to exhibit the fastest growth.
Market size
Growth trajectory through 2035
Long-term Care Software Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
Development 01 AI and predictive analytics integration
- Vendors are increasingly incorporating AI-driven tools to enhance care planning, predict patient deterioration, and optimize staffing.
-
Development 02 Telehealth expansion
- Long-term care software providers are integrating telehealth capabilities to support remote patient monitoring and virtual consultations.
-
Development 03 Regulatory updates
- New healthcare regulations, such as those mandating interoperability and data sharing, are driving vendors to update their platforms for compliance.
-
Development 04 Partnerships with EHR vendors
- Collaborations between long-term care software providers and EHR vendors aim to improve data exchange and care coordination.
Emerging opportunities added
- Expansion of telehealth and remote monitoring Integration of telehealth capabilities into long-term care software enables remote patient monitoring, reducing in-person visits and improving care continuity.
- AI and predictive analytics adoption Artificial intelligence-driven analytics can enhance care planning, predict patient deterioration, and optimize staffing and resource allocation.
- Hybrid and modular software solutions Providers increasingly seek flexible, modular software that can scale with their needs and integrate with existing systems, creating opportunities for vendors offering customizable platforms.
- Partnerships with EHR and telemedicine platforms Collaborations between long-term care software vendors and broader healthcare IT ecosystems can expand market reach and enhance interoperability.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $2.77 Bn
- CAGR
- 11.00%
- Expansion
- 2.8×
Market shape
top segment · 40.7% share
- Leading region
- North America
- Top end-user
- growing segment, fueled by the shift toward aging in place and community
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High implementation and maintenance costs
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
AI and predictive analytics integration: Vendors are increasingly incorporating AI-driven tools to enhance care planning, predict patient deterioration, and optimize staffing
+4 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 130-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Long-term Care Software Market today ($2.77 Bn base), and how fast will it grow at 11.0% CAGR through 2035?
- Which of intensive care environments holds the largest share, and how do the growth rates diverge?
- How is demand distributed across chart, template="vbar_classic" data, palette="muted_green"> applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America, and MEA compare on market share and growth rate?
- Where do GSK plc, Pfizer Inc, Johnson & Johnson and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Aging population and chronic disease prevalence) and top restraints (led by High implementation and maintenance costs), with quantified CAGR impact?
- What regulatory shifts and 5 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Aging population and chronic disease prevalence The global demographic shift toward an older population increases demand for long-term care services, necessitating software solutions that enhance efficiency and care quality.
- Adoption of electronic health records (EHRs) Widespread integration of EHRs across care facilities improves documentation accuracy, interoperability, and regulatory compliance, driving software adoption.
- Regulatory compliance and reporting requirements Evolving healthcare regulations mandate robust data management and reporting, compelling providers to invest in compliant software platforms.
- Operational efficiency and cost reduction Long-term care facilities seek software to automate workflows, reduce administrative burdens, and optimize staffing and resource allocation.
- Technological advancements in cloud and mobile solutions Cloud-based and mobile-enabled software solutions offer scalability, accessibility, and real-time data synchronization, supporting decentralized care models.
Restraints
Holding it back
- High implementation and maintenance costs The upfront and ongoing costs of long-term care software, including licensing, training, and IT infrastructure, pose financial barriers for smaller facilities.
- Data security and privacy concerns Handling sensitive patient data requires stringent security measures, increasing compliance costs and operational complexity.
- Resistance to digital transformation Some care providers, particularly in rural or under-resourced regions, may lack the infrastructure or workforce readiness to adopt new software systems.
- Interoperability challenges Fragmented healthcare systems and legacy software often hinder seamless data exchange between long-term care facilities and other healthcare providers.
- Regulatory uncertainty Frequent changes in healthcare regulations and reimbursement policies create uncertainty, delaying investment in new software solutions.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Aging population and chronic disease prevalence | +5.0% | Global | 2025–2035 |
| Adoption of electronic health records (EHRs) | +3.1% | Global | 2025–2035 |
| Regulatory compliance and reporting requirements | +2.4% | Global | 2025–2035 |
| Operational efficiency and cost reduction | +1.7% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High implementation and maintenance costs | −2.0% | Global | 2025–2029 |
| Data security and privacy concerns | −1.3% | Global | 2025–2029 |
| Resistance to digital transformation | −1.0% | Global | 2025–2029 |
Total 6 EHR (Electronic 50% eMAR (electronic 33% Payroll Manageme 17% The long-term care software market is segmented by product, mode of delivery, end-user, and application, reflecting the diverse needs of care providers.
Revenue share by type · 2025 base year
% OF $2.77 BN LONG-TERM CARE SOFTWARE MARKET · 4 TYPES COVERED
Each slice = that type's share of the total $2.77 Bn Long-term Care Software Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
intensive care environments
By application
-
chart
-
template="vbar_classic" data
-
palette="muted_green">
-
size="15" fill="#0f172a" text
-
anchor="middle" font
-
weight="bold">Regional Coverage
-
size="11" fill="#065f46" text
-
weight="bold">5
By end-user industry
-
growing segment, fueled by the shift toward aging in place and community
-
based care
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $2.77 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~42.7% in 2025. Driven by manufacturing scale and end-market density.
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The long-term care software market is moderately fragmented, with a mix of established vendors and emerging players. Competition is driven by product innovation, pricing, and the ability to integrate with broader healthcare ecosystems.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
GSK plc
Rank 01Share est. ~16%Revenue $38B FYHQ UK · London -
Pfizer Inc
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Johnson & Johnson
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Roche Holding AG
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Novartis AG
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Merck & Co., Inc
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
AbbVie Inc
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
Eli Lilly and Company
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA CDER/CBER approves new drugs and biologics; typical NDA review 10 months (standard), 6 months (priority). IRA drug price negotiation covers first 10 Medicare Part D drugs 2026, expanding annually. CMS coverage decisions gate market access. State-level PBM reform + 340B changes reshape distribution.
-
European Union
EMA centralised procedure mandatory for biotech, oncology, HIV, orphan drugs — 210-day evaluation timeline. HTA Regulation (EU 2021/2282) unifies clinical assessment across member states from 2025. Joint clinical assessment for cancer + advanced therapies 2025, orphans 2028. GDPR + national health data laws govern secondary use of clinical data.
-
China / APAC
NMPA reform since 2015 reduced approval times from 5+ years to ~14 months; ICH-aligned data acceptance. Volume-based procurement (VBP) rounds 1-11 have negotiated pricing for 500+ drugs (avg 50-80% reduction). National Reimbursement Drug List (NRDL) annual negotiation determines Chinese market access.
-
Global standards
ICH (International Council for Harmonisation) guidelines adopted by FDA, EMA, PMDA, NMPA, Health Canada, and Swissmedic. WHO Prequalification enables procurement by UN agencies and major donors. USP, EP, JP pharmacopoeia standards govern drug quality worldwide. GxP quality standards (GCP, GMP, GLP, GVP) universal.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
What is the worth of the global long-term care software market?
The global long-term care software market was valued at 1.63 billion in 2022 and is projected to reach 4.8 billion by 2029, growing at a CAGR of 12.6% from 2022 to 2029 -
Which market segments are covered in the report on the long-term care software market?
Based on product, mode of delivery, end-user, and region the long-term care software market reports divisions are broken down. -
What is the CAGR of the long-term care software market?
The global long-term care software market registered a CAGR of 12.6% from 2022 to 2029. The industry segment was the highest revenue contributor to the market. -
Which are the top companies to hold the market share in the long-term care software market?
Key players profiled in the report include Cerner Corporation, Omnicare Inc., AOD Software, Kronos, PointClickCare, Omnicell, McKesson Corporation, Allscripts Healthcare Solutions, Inc., MatrixCare, SigmaCare, Optimus EMR, and HealthMEDX LLC. -
Which is the largest regional market for the long-term care software market?
The North American long-term care software industry was dominated by the us in 2022. This is because new technological software services are widely adopted in the nation. For instance, the drug enforcement administration (DEA) now permits medical professionals to electronically dispense controlled substances.
The Long-term Care Software Market is projected to reach $7.87 Bn by 2035, up from $2.77 Bn in 2025 — a 11.00% CAGR equating to roughly 2.8× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.